Rehabilitation Robots Market Set for Rapid Growth as AI, Exoskeletons and Home-Based Therapy Transform Patient Care

Rehabilitation Robots Market Overview and Growth Drivers

The global Rehabilitation Robots Market is entering a high-growth phase as healthcare providers increasingly adopt robotic technologies to improve mobility, gait training, and recovery outcomes for patients with neurological and physical impairments. According to Maximize Market Research, the market was valued at USD 429.1 million in 2025 and is expected to grow at a CAGR of 15.2% from 2026 to 2032, reaching nearly USD 1,155.38 million by 2032. Rehabilitation robots provide repetitive, precise, and data-driven assistance to patients recovering from stroke, spinal cord injuries, multiple sclerosis, Parkinson’s disease, and other mobility-related conditions. Rising neurological disorders, an aging global population, increasing demand for personalized therapy, and shortages of rehabilitation professionals are supporting adoption. Integration of artificial intelligence, motion sensors, cloud computing, and brain-computer interface technologies is creating additional opportunities by allowing robotic systems to adjust therapy intensity and monitor patient progress. Home-based rehabilitation is another major opportunity as portable exoskeletons and remote-monitoring technologies make long-term therapy more accessible. However, high equipment costs, maintenance requirements, professional training, and limited reimbursement in some markets remain important barriers to widespread adoption.

* Experience It Before Others: https://www.maximizemarketresearch.com/request-sample/105748/ 

U.S. Market Trends and Investment

The United States remains one of the most important markets for rehabilitation robotics because of its advanced healthcare infrastructure, established robotics industry, high prevalence of stroke and spinal cord injuries, and regulatory pathway for innovative medical devices. In 2025, U.S. rehabilitation robotics activity accelerated through product innovation and regulatory progress. The FDA granted 510(k) clearance to Lifeward’s ReWalk 7 Personal Exoskeleton in March 2025, supporting the availability of its next-generation powered exoskeleton for individuals with spinal cord injury. In May 2025, Ekso Bionics was accepted into NVIDIA’s Connect program and announced plans to develop a foundation model for human motion in physical rehabilitation, with the goal of integrating advanced AI capabilities across its exoskeleton platforms. Meanwhile, Wandercraft announced a USD 75 million Series D financing round in June 2025 to accelerate AI-powered exoskeleton development and clinical adoption. These developments indicate that U.S. investment is moving beyond conventional robotic assistance toward AI-enabled, personalized, and potentially home-oriented rehabilitation.

Market Segmentation: Exoskeletons Hold the Largest Share

Based on type, the Exoskeletons segment holds the largest market share and is expected to dominate the Rehabilitation Robots Market. Exoskeletons are gaining adoption because they can support patients with gait and mobility impairments while enabling repetitive rehabilitation exercises. They are particularly valuable for people affected by spinal cord injuries, stroke, Parkinson’s disease, and other neurological conditions. MMR highlights the role of robotic exoskeletons in helping patients stand, walk, turn, and improve natural gait. Increasing technological development, including adaptive assistance, real-time feedback, and AI-based gait adjustment, is expected to strengthen this segment’s position.

Rehabilitation Robots Market Key Players
CYBERDYNE Inc.
Ekso Bionics Holdings Inc.
ReWalk Robotics Ltd.
DIH Medical (Hocoma AG)
Bionik Laboratories Corp.
Rex Bionics Ltd.
Tyromotion GmbH
Rehab-Robotics Company Limited
Fourier Intelligence
Myomo Inc.
Kinova Robotics
KUKA AG
Parker Hannifin Corporation
Siemens Healthineers
Medtronic plc
Bioness Inc.
AlterG Inc.
Honda Motor Co. (Robotics Division)
Panasonic Holdings Corporation
Samsung Electronics Co., Ltd.
Barrett Technology LLC
Interactive Motion Technologies
Reha Technology AG
Wandercraft
Innophys Co., Ltd.
Hocoma AG (DIH Group)
Life Science Robotics ApS
Hocoma & DIH (Integrated Rehabilitation Systems)
AlterG (Rehabilitation Systems Division)
BionX Medical Technologies

Competitive Analysis

The MMR report identifies CYBERDYNE Inc., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd., DIH Medical (Hocoma AG), and Bionik Laboratories Corp. among the leading companies in the market. The MMR page does not disclose individual company market-share percentages, so specific shares have not been assigned.

CYBERDYNE Inc. continues to advance wearable robotics through its HAL technology, which uses biological electrical signals to assist voluntary movement. In 2025, clinical evidence published in the Global Spine Journal highlighted the potential of actively controlled exoskeletons to support neuroplasticity and functional recovery following spinal cord injury. CYBERDYNE also continues developing integrated rehabilitation environments around HAL technology.

Ekso Bionics is increasingly integrating AI into rehabilitation robotics. Its 2025 NVIDIA Connect initiative aims to develop a human-motion foundation model that can support AI capabilities across its rehabilitation devices. Such technology could enable more adaptive therapy and individualized gait assistance.

ReWalk Robotics, now operating as Lifeward, strengthened its U.S. product portfolio through FDA clearance of ReWalk 7 in March 2025. The device represents a new generation of personal exoskeleton technology for people with spinal cord injury.

DIH Medical (Hocoma AG) continues to focus on robotic and sensor-based rehabilitation solutions. Its technology portfolio supports data-driven therapy and personalized rehabilitation, positioning the company to benefit from the transition toward technology-assisted clinical care.

Bionik Laboratories is another important participant in robotic rehabilitation, with its focus on intelligent therapy systems designed to support upper-extremity recovery. Increasing demand for measurable and repeatable rehabilitation outcomes provides opportunities for such robotic platforms.

Regional Analysis: United States

The United States is the key contributor to the dominant North American market. MMR estimates that North America accounts for approximately 40%–45% of global Rehabilitation Robots Market share, supported by advanced healthcare infrastructure, medical robotics adoption, reimbursement frameworks, and increasing cases of stroke and spinal cord injuries. The country's established rehabilitation centers, VA medical facilities, major robotics companies, and FDA approvals provide a strong foundation for market expansion. Continued development of wearable exoskeletons, AI-based therapy, and home rehabilitation solutions is expected to create further opportunities. U.S. reimbursement development is also important because improved coverage can help healthcare providers and patients overcome the high upfront cost of robotic systems.

Related Reports: 

Global Lid Applicator Machine Market https://www.maximizemarketresearch.com/market-report/global-lid-applicator-machine-market/116944/ 

Global Electric Hedge Trimmer Market https://www.maximizemarketresearch.com/market-report/global-electric-hedge-trimmer-market/106982/ 

Global Crane and Hoist Market https://www.maximizemarketresearch.com/market-report/global-crane-and-hoist-market/100788/ 

Conclusion

The Rehabilitation Robots Market offers substantial growth potential as healthcare moves toward personalized, technology-assisted recovery. The strongest opportunities are emerging in AI-powered exoskeletons, adaptive gait systems, wearable rehabilitation devices, remote monitoring, home-based therapy, and data-driven treatment. Falling technology costs, stronger clinical evidence, expanded reimbursement, and regulatory approvals could accelerate adoption. In the longer term, combining robotics with AI, sensors, cloud platforms, and neural-interface technologies could transform rehabilitation from therapist-intensive treatment into a more continuous, personalized, and measurable care model.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 sales@maximizemarketresearch.com